These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21539743)

  • 21. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.
    Cavallazzi R; El-Kersh K; Abu-Atherah E; Singh S; Loke YK; Wiemken T; Ramirez J
    Respir Med; 2014 Nov; 108(11):1569-80. PubMed ID: 25448309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.
    Schuetz P; Litke A; Albrich WC; Mueller B
    Curr Opin Infect Dis; 2013 Apr; 26(2):159-67. PubMed ID: 23434895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection.
    Hartmann O; Schuetz P; Albrich WC; Anker SD; Mueller B; Schmidt T
    Int J Cardiol; 2012 Nov; 161(3):166-73. PubMed ID: 23017815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Mid-Region Proadrenomedullin and In Vitro Interferon Gamma Production for In-Hospital Mortality in Patients with COVID-19 Pneumonia and Respiratory Failure: An Observational Prospective Study.
    Mangioni D; Oggioni M; Chatenoud L; Liparoti A; Uceda Renteria S; Alagna L; Biscarini S; Bolis M; Di Modugno A; Mussa M; Renisi G; Ungaro R; Muscatello A; Gori A; Ceriotti F; Bandera A
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable State Proadrenomedullin Level in COPD Patients: A Validation Study.
    Zuur-Telgen M; VanderValk P; van der Palen J; Kerstjens HA; Brusse-Keizer M
    COPD; 2017 Apr; 14(2):219-227. PubMed ID: 27880050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proadrenomedullin Predicts Severe Disease in Children With Suspected Community-acquired Pneumonia.
    Florin TA; Ambroggio L; Brokamp C; Zhang Y; Nylen ES; Rattan M; Crotty E; Belsky MA; Krueger S; Epperson TN; Kachelmeyer A; Ruddy RM; Shah SS
    Clin Infect Dis; 2021 Aug; 73(3):e524-e530. PubMed ID: 32761072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable-State Midrange Proadrenomedullin Is Associated With Severe Exacerbations in COPD.
    Citgez E; Zuur-Telgen M; van der Palen J; van der Valk P; Stolz D; Brusse-Keizer M
    Chest; 2018 Jul; 154(1):51-57. PubMed ID: 29475034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study.
    Kutz A; Hausfater P; Amin D; Amin A; Canavaggio P; Sauvin G; Bernard M; Conca A; Haubitz S; Struja T; Huber A; Mueller B; Schuetz P;
    PLoS One; 2016; 11(12):e0168076. PubMed ID: 28005916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
    Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
    Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
    Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Liu D; Xie L; Zhao H; Liu X; Cao J
    BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD.
    Zuur-Telgen MC; Brusse-Keizer MG; VanderValk PD; van der Palen J; Kerstjens HA; Hendrix MG
    Chest; 2014 Mar; 145(3):534-541. PubMed ID: 27845633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidimensional Prognostic Index and pro-adrenomedullin plasma levels as mortality risk predictors in older patients hospitalized with community-acquired pneumonia: a prospective study.
    Pilotto A; Dini S; Veronese N; Daragjati J; Miolo M; Mion MM; Fontana A; Lo Storto M; Zaninotto M; Bragato G; Cella A; Carraro P; Addante F; Copetti M; Plebani M
    Panminerva Med; 2018 Sep; 60(3):80-85. PubMed ID: 29546738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection.
    Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; Delfos NM; Leyten EMS; Koster T; Ablij HC; Van't Wout JJW; van Dissel JT
    J Infect; 2018 Jul; 77(1):18-24. PubMed ID: 29807091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children.
    Peñalver Penedo R; Rupérez Lucas M; Álvarez-Sala Walther LA; Torregrosa Benavent A; Casas Losada ML; Bañuelos Andrio L; Rebolledo Poves AB; Bueno Campaña M
    BMC Pediatr; 2021 Jun; 21(1):292. PubMed ID: 34187408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.